BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Genetown

  Coffee May Lower Risk Of Type 2 Diabetes

  February 9, 2006

   · 

  1 min read
• Biotech Beach

  Macrophage Signaling May Affect Hormone Resistance In Prostate Tumors

  February 9, 2006

   · 

  1 min read
• BioCapital

  High Resolution ‘Snapshots’ Detail Dynamics Of A Cocaine Antibody

  February 9, 2006

   · 

  1 min read
• Pharm Country

  New York State Urged To Create Stem Cell Research Fund

  February 9, 2006

   · 

  1 min read
• Business

  2 Maryland Biotech Firms Report Big Losses

  February 9, 2006

   · 

  1 min read
• BioCapital

  New Side Effect Panel From NovaScreen Biosciences Corporation Identifies Potential Risk Factors Of Drug Candidates

  February 9, 2006

   · 

  2 min read
• Drug Development

  Gilead Sciences (Foster City, CA) Announces Results From Phase I/II Study Of Investigational HIV Integrase Inhibitor GS 9137

  February 9, 2006

   · 

  1 min read
• BioMidwest

  American Academy of Allergy, Asthma and Immunology (AAAAI) Release: Health Disparities In Asthma Highlighted In February Issue Of Journal Of Allergy And Clinical Immunology

  February 9, 2006

   · 

  4 min read
• Drug Development

  Merck & Co., Inc. Announces Interim Results From Phase II Study Of MK-0518, An Investigational Oral HIV Integrase Inhibitor

  February 9, 2006

   · 

  1 min read
• Drug Development

  NeurogesX, Inc. Announces Presentation Of Positive Phase 3 Results In Painful HIV-Associated Neuropathy

  February 9, 2006

   · 

  1 min read